These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22875636)

  • 21. Ventral posterior substantia nigra iron increases over 3 years in Parkinson's disease.
    Bergsland N; Zivadinov R; Schweser F; Hagemeier J; Lichter D; Guttuso T
    Mov Disord; 2019 Jul; 34(7):1006-1013. PubMed ID: 31180615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage.
    Zecca L; Berg D; Arzberger T; Ruprecht P; Rausch WD; Musicco M; Tampellini D; Riederer P; Gerlach M; Becker G
    Mov Disord; 2005 Oct; 20(10):1278-85. PubMed ID: 15986424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
    An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
    J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential sources of increased iron in the substantia nigra of parkinsonian patients.
    Gerlach M; Double KL; Youdim MB; Riederer P
    J Neural Transm Suppl; 2006; (70):133-42. PubMed ID: 17017520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance imaging assessment of substantia nigral iron deposition in Parkinson's disease: a meta-analysis.
    Liu GL; Zhang HW; Zha CB; Fan TW; Chen ST; Shen TT; He K
    Eur Rev Med Pharmacol Sci; 2024 Feb; 28(3):899-906. PubMed ID: 38375696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury.
    Berg D; Roggendorf W; Schröder U; Klein R; Tatschner T; Benz P; Tucha O; Preier M; Lange KW; Reiners K; Gerlach M; Becker G
    Arch Neurol; 2002 Jun; 59(6):999-1005. PubMed ID: 12056937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The whole-brain pattern of magnetic susceptibility perturbations in Parkinson's disease.
    Acosta-Cabronero J; Cardenas-Blanco A; Betts MJ; Butryn M; Valdes-Herrera JP; Galazky I; Nestor PJ
    Brain; 2017 Jan; 140(1):118-131. PubMed ID: 27836833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controversies about iron in parkinsonian and control substantia nigra.
    Gałazka-Friedman J; Friedman A
    Acta Neurobiol Exp (Wars); 1997; 57(3):217-25. PubMed ID: 9407708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcranial brain sonography findings in Parkinson's disease: implications for pathogenesis, early diagnosis and therapy.
    Walter U
    Expert Rev Neurother; 2009 Jun; 9(6):835-46. PubMed ID: 19496687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nigral iron elevation is an invariable feature of Parkinson's disease and is a sufficient cause of neurodegeneration.
    Ayton S; Lei P
    Biomed Res Int; 2014; 2014():581256. PubMed ID: 24527451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.
    Jin L; Wang J; Zhao L; Jin H; Fei G; Zhang Y; Zeng M; Zhong C
    Brain; 2011 Jan; 134(Pt 1):50-8. PubMed ID: 21109502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Freezing of gait in early Parkinson's disease: Nigral iron content estimated from magnetic resonance imaging.
    Wieler M; Gee M; Camicioli R; Martin WR
    J Neurol Sci; 2016 Feb; 361():87-91. PubMed ID: 26810522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no.
    Walter U
    J Neural Transm (Vienna); 2011 Apr; 118(4):607-12. PubMed ID: 21190047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcranial sonography of the substantia nigra and its correlation with DAT-SPECT in the diagnosis of Parkinson's disease.
    Li DH; Zhang LY; Hu YY; Jiang XF; Zhou HY; Yang Q; Kang WY; Liu J; Chen SD
    Parkinsonism Relat Disord; 2015 Aug; 21(8):923-8. PubMed ID: 26066091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigations of differences in iron oxidation state inside single neurons from substantia nigra of Parkinson's disease and control patients using the micro-XANES technique.
    Chwiej J; Adamek D; Szczerbowska-Boruchowska M; Krygowska-Wajs A; Wojcik S; Falkenberg G; Manka A; Lankosz M
    J Biol Inorg Chem; 2007 Feb; 12(2):204-11. PubMed ID: 17120075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease.
    Gorell JM; Ordidge RJ; Brown GG; Deniau JC; Buderer NM; Helpern JA
    Neurology; 1995 Jun; 45(6):1138-43. PubMed ID: 7783878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic resonance relaxometry in Parkinson's disease.
    Mondino F; Filippi P; Magliola U; Duca S
    Neurol Sci; 2002 Sep; 23 Suppl 2():S87-8. PubMed ID: 12548357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.
    He N; Ling H; Ding B; Huang J; Zhang Y; Zhang Z; Liu C; Chen K; Yan F
    Hum Brain Mapp; 2015 Nov; 36(11):4407-20. PubMed ID: 26249218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study.
    Good PF; Olanow CW; Perl DP
    Brain Res; 1992 Oct; 593(2):343-6. PubMed ID: 1450944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical MRI for iron detection in Parkinson's disease.
    Rossi M; Ruottinen H; Soimakallio S; Elovaara I; Dastidar P
    Clin Imaging; 2013; 37(4):631-6. PubMed ID: 23522789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.